ORTHODONTIX 10KSB 12/31/03

Company

Protalix BioTherapeutics, Inc.

Filed

March 30, 2004

Period of Report

December 31, 2003

Accession Number

0001006281-04-000003

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →